Actinorhodin (CED0006307)

Record Information
Version1.0
Creation Date2026-03-31 20:57:52 UTC
Update Date2026-05-20 19:29:01 UTC
SynCED IDCED0006307
Secondary Accession Numbers
  • CHEM057925
Identification
Common NameActinorhodin
ClassSmall Molecule
Description
Actinorhodin is an organic compound with the chemical formula C32H26O14. Actinorhodin belongs to the lignans, neolignans and related compounds, a superclass within the organic compounds. This substance is found in or released from one recorded source: healthcare, pharmaceuticals & veterinary products, specifically antibiotics. Recorded exposure routes for this compound include inhalation and oral ingestion.
Contaminant TypeNot Available
Chemical Structure
SynonymsNot Available
Chemical FormulaC32H26O14
Average Molecular MassNot Available
Monoisotopic Mass634.132 g/mol
CAS Registry NumberNot Available
IUPAC NameNot Available
Traditional NameNot Available
SMILESNot Available
InChI IdentifierInChI=1S/C32H26O14/c1-9-21-15(3-11(45-9)5-19(35)36)29(41)23-17(33)7-13(27(39)25(23)31(21)43)14-8-18(34)24-26(28(14)40)32(44)22-10(2)46-12(6-20(37)38)4-16(22)30(24)42/h7-12,33-34,39-40H,3-6H2,1-2H3,(H,35,36)(H,37,38)/t9-,10-,11+,12+/m1/s1
InChI KeyVTIKDEXOEJDMJP-WYUUTHIRSA-N
Chemical Taxonomy
ClassificationNot classified
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted PropertiesNot Available
Spectra
SpectraNot Available
Toxicity Profile
Toxicity Values
Toxicity ValueOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalToxicity RatingReference
6930.0 Log mg/kg [3900:12000]RatLD50oralpredictedNot AvailableNot Available
Toxicity / Toxin ClassNot Available
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
CEDs000306Antibiotics?Antibiotics are synthetic or semi-synthetic compounds used to treat bacterial infections in humans and animals.Healthcare, pharmaceuticals & veterinary productsNot Available
CEDs000545Food Preservation?Food preservation often involves the use of synthetic chemicals, such as preservatives, flavor enhancers, and color additives, to extend shelf life and enhance the sensory qualities of food products.Food, food processing & cookwareNot Available
CEDs000642Footwear?Footwear production often involves the use of various synthetic chemicals, such as adhesives, dyes, and treatments, which can contribute to environmental contamination.Textiles, leather & furnishingsNot Available
CEDs000696Nanotechnology?Nanotechnology involves the manipulation of materials at the molecular or atomic level, typically within the range of 1 to 100 nanometers.Industrial manufacturing & chemical processingNot Available
CEDs000739Inks?Inks are complex mixtures composed of pigments or dyes, solvents, resins, and additives used primarily for printing and writing applications.Paper, pulp & fiber productsNot Available
CEDs000740Paper?Paper production involves the processing of wood fibers and the use of various chemicals, which can lead to synthetic chemical contamination.Paper, pulp & fiber productsNot Available
Pathways
0 pathwaysPathway Source: PathBank

No pathways found

No metabolic pathways have been associated with this synthetic chemical

Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Induced myeloid leukemia cell differentiation protein Mcl-1 structureClick to view 3D structureInduced myeloid leukemia cell differentiation protein Mcl-1Q07820HumansPredicted (SEA)
Prediction Confidence Score
0.239
Applicability Domain
0.27 Low confidence
Statistical Significance
0.1486
Supporting Reference Compounds
343
E-value
1157.23
Click to view 3D structureSqualene monooxygenaseP52020Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.236
Applicability Domain
0.245 Low confidence
Statistical Significance
0.0011
Supporting Reference Compounds
12
E-value
8.56341
Cytochrome P450 1B1 structureClick to view 3D structureCytochrome P450 1B1Q16678HumansPredicted (SEA)
Prediction Confidence Score
0.235
Applicability Domain
0.283 Low confidence
Statistical Significance
0.0435
Supporting Reference Compounds
88
E-value
339.033
Click to view 3D structureStreptokinase AP10520Streptococcus pyogenes serotype M1Predicted (SEA)
Prediction Confidence Score
0.23
Applicability Domain
0.27 Low confidence
Statistical Significance
0.2733
Supporting Reference Compounds
425
E-value
2127.85
Platelet-derived growth factor receptor alpha structureClick to view 3D structurePlatelet-derived growth factor receptor alphaP16234HumansPredicted (SEA)
Prediction Confidence Score
0.227
Applicability Domain
0.243 Low confidence
Statistical Significance
0.4559
Supporting Reference Compounds
519
E-value
3549.15
Vascular endothelial growth factor receptor 2 structureClick to view 3D structureVascular endothelial growth factor receptor 2P35968HumansPredicted (SEA)
Prediction Confidence Score
0.227
Applicability Domain
0.243 Low confidence
Statistical Significance
0.6737
Supporting Reference Compounds
1660
E-value
5244.7
Receptor-type tyrosine-protein kinase FLT3 structureClick to view 3D structureReceptor-type tyrosine-protein kinase FLT3P36888HumansPredicted (SEA)
Prediction Confidence Score
0.225
Applicability Domain
0.243 Low confidence
Statistical Significance
0.6516
Supporting Reference Compounds
1274
E-value
5073.04
Acetylcholinesterase structureClick to view 3D structureAcetylcholinesteraseP22303HumansPredicted (SEA)
Prediction Confidence Score
0.224
Applicability Domain
0.283 Low confidence
Statistical Significance
0.363
Supporting Reference Compounds
406
E-value
2825.62
Vascular endothelial growth factor receptor 3 structureClick to view 3D structureVascular endothelial growth factor receptor 3P35916HumansPredicted (SEA)
Prediction Confidence Score
0.224
Applicability Domain
0.243 Low confidence
Statistical Significance
0.5513
Supporting Reference Compounds
687
E-value
4291.67
Estrogen receptor beta structureClick to view 3D structureEstrogen receptor betaQ92731HumansPredicted (SEA)
Prediction Confidence Score
0.222
Applicability Domain
0.239 Low confidence
Statistical Significance
0.1698
Supporting Reference Compounds
174
E-value
1321.65
Mast/stem cell growth factor receptor Kit structureClick to view 3D structureMast/stem cell growth factor receptor KitP10721HumansPredicted (SEA)
Prediction Confidence Score
0.221
Applicability Domain
0.236 Low confidence
Statistical Significance
0.6308
Supporting Reference Compounds
905
E-value
4910.88
Estrogen receptor structureClick to view 3D structureEstrogen receptorP03372HumansPredicted (SEA)
Prediction Confidence Score
0.221
Applicability Domain
0.239 Low confidence
Statistical Significance
0.1507
Supporting Reference Compounds
201
E-value
1173.5
Aromatase structureClick to view 3D structureAromataseP11511HumansPredicted (SEA)
Prediction Confidence Score
0.221
Applicability Domain
0.234 Low confidence
Statistical Significance
0.0859
Supporting Reference Compounds
127
E-value
668.803
Tyrosine-protein kinase Lck structureClick to view 3D structureTyrosine-protein kinase LckP06239HumansPredicted (SEA)
Prediction Confidence Score
0.22
Applicability Domain
0.236 Low confidence
Statistical Significance
0.7118
Supporting Reference Compounds
1130
E-value
5541.7
Mediator of RNA polymerase II transcription subunit 25 structureClick to view 3D structureMediator of RNA polymerase II transcription subunit 25Q71SY5HumansPredicted (SEA)
Prediction Confidence Score
0.219
Applicability Domain
0.219 Low confidence
Statistical Significance
5.20e-04
Supporting Reference Compounds
1
E-value
4.04816
Aldo-keto reductase family 1 member B1 structureClick to view 3D structureAldo-keto reductase family 1 member B1P15121HumansPredicted (SEA)
Prediction Confidence Score
0.219
Applicability Domain
0.247 Low confidence
Statistical Significance
0.0808
Supporting Reference Compounds
84
E-value
629.022
P2Y purinoceptor 12 structureClick to view 3D structureP2Y purinoceptor 12Q9H244HumansPredicted (SEA)
Prediction Confidence Score
0.219
Applicability Domain
0.247 Low confidence
Statistical Significance
0.0251
Supporting Reference Compounds
49
E-value
195.168
Mitogen-activated protein kinase 1 structureClick to view 3D structureMitogen-activated protein kinase 1P28482HumansPredicted (SEA)
Prediction Confidence Score
0.218
Applicability Domain
0.236 Low confidence
Statistical Significance
0.6475
Supporting Reference Compounds
763
E-value
5040.58
Cytochrome P450 1A1 structureClick to view 3D structureCytochrome P450 1A1P04798HumansPredicted (SEA)
Prediction Confidence Score
0.216
Applicability Domain
0.283 Low confidence
Statistical Significance
0.0669
Supporting Reference Compounds
77
E-value
521.123
Click to view 3D structureGag-Pol polyproteinQ7ZJM1Human immunodeficiency virus 1Predicted (SEA)
Prediction Confidence Score
0.216
Applicability Domain
0.238 Low confidence
Statistical Significance
0.0688
Supporting Reference Compounds
96
E-value
535.758
Click to view 3D structureNS3A3EZJ3Hepatitis C virusPredicted (SEA)
Prediction Confidence Score
0.215
Applicability Domain
0.224 Low confidence
Statistical Significance
0.0704
Supporting Reference Compounds
70
E-value
547.747
Amine oxidase [flavin-containing] A structureClick to view 3D structureAmine oxidase [flavin-containing] AP21397HumansPredicted (SEA)
Prediction Confidence Score
0.215
Applicability Domain
0.283 Low confidence
Statistical Significance
0.2919
Supporting Reference Compounds
241
E-value
2272.81
Beta-secretase 1 structureClick to view 3D structureBeta-secretase 1P56817HumansPredicted (SEA)
Prediction Confidence Score
0.212
Applicability Domain
0.237 Low confidence
Statistical Significance
0.2618
Supporting Reference Compounds
163
E-value
2037.78
Ephrin type-B receptor 4 structureClick to view 3D structureEphrin type-B receptor 4P54760HumansPredicted (SEA)
Prediction Confidence Score
0.212
Applicability Domain
0.236 Low confidence
Statistical Significance
0.4126
Supporting Reference Compounds
259
E-value
3212.14
ALK tyrosine kinase receptor structureClick to view 3D structureALK tyrosine kinase receptorQ9UM73HumansPredicted (SEA)
Prediction Confidence Score
0.212
Applicability Domain
0.236 Low confidence
Statistical Significance
0.7036
Supporting Reference Compounds
708
E-value
5477.86
Concentrations
Not Available
External Links
IdentifiersNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available